相关实验视频

Updated: Sep 10, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

异常的DNA甲基化和NR0B1的过度表达是KEAP1突变肺腺癌的预后生物标志物

Mohamed Elshaer^1,2,3,4, Ahmed Hammad^1,2,5, Yang Gao^1,2

¹Department of Respiratory and Critical Care Medicine, Center for Oncology Medicine, International School of Medicine, The Fourth Affiliated Hospital of School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China.

Discover oncology

|August 27, 2025

概括

肺腺癌中KEAP1突变与NR0B1促进体低甲基化和过度表达有关,与患者的生存率差相关. 这表明癌症的进展和潜在的抗药性.

科学领域:

癌症学
分子生物学
表观遗传学

背景情况:

KEAP1-NRF2通路对于细胞防御氧化应激至关重要.
癌细胞,特别是非小细胞肺癌 (NSCLC),通过突变KEAP1或NRF2来利用这种途径来促进抗氧化基因转录.
作为NRF2的点,NR0B1支持KEAP1突变NSCLC的独立成长.

研究的目的:

研究KEAP1突变,NR0B1促进物甲基化,NR0B1基因表达和肺腺癌 (LUAD) 患者存活率之间的关系.
探索关联KEAP1突变与LUAD中的NR0B1过度表达的分子机制.

主要方法:

多种体质分析
湿实验室实验
对KEAP1突变的相关性分析,NR0B1促进物甲基化状态 (特别是cg22696549),NR0B1基因表达和LUAD中的患者生存数据.

主要成果:

与野生型相比,KEAP1突变的LUAD细胞系和患者样本呈现出显著的NR0B1促进体低甲基化和过度表达.
在KEAP1突变的LUAD中,NR0B1促进物低甲基化与NR0B1基因表达之间存在强烈的负相关性.
在LUAD患者中,NR0B1促进剂低甲基化 (cg22696549) 和NR0B1过度表达与低生存率和更糟糕的预后有关.

结论:

与KEAP1突变相关的DNA甲基化变化和NRF2可能会在LUAD中促进NR0B1的过度表达.
在LUAD进展中,NR0B1起着重要作用.
这些发现提高了对NR0B1在肺癌进展和耐药性的理解,表明了潜在的治疗点.

关键词:

DNA 甲基化一个KEAP1 肺部癌症 NR0B1 其他其他类型

更多相关视频

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Epigenetic Regulation

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...